ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 060,10
-0,06%
Dow Jones
38 386,09
0,38%
DAX
18 050,00
-0,45%
Brent Oil
87,625
0,39%
Bitcoin
61 485,00
-3,69%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cumberland Pharmaceutical Inc (CPIX)

  7. Cumberland Pharmaceutical Inc (CPIX) Actualités

CPIX Cumberland Pharmaceutical Inc

1,695
0,00 (0,00%)
Avant marché
Dernière mise à jour : 13:00:11
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cumberland Pharmaceutical Inc CPIX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 1,695 13:00:11
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,695
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/4/202422:05PRNUSNEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE..
05/3/202423:10EDGAR2Form 8-K - Current report
05/3/202422:05PRNUSCumberland Pharmaceuticals Reports Annual 2023 Financial..
27/2/202422:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL..
09/2/202423:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/12/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
15/12/202322:14EDGAR2Form DEL AM - Delaying amendment
14/12/202323:09EDGAR2Form S-3 - Registration statement under Securities Act of..
06/12/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202323:21EDGAR2Form 8-K - Current report
07/11/202322:05PRNUSCumberland Pharmaceuticals Reports Third Quarter 2023..
03/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202321:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023..
17/10/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202315:11EDGAR2Form 8-K - Current report
10/10/202322:05PRNUSNEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN..
03/10/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202316:55DJNCorrection to SEC Fines Article
27/9/202316:43DJNSEC Fines 5 Public Companies, Insiders Over Reporting..
19/9/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202323:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202323:23EDGAR2Form 8-K - Current report
08/8/202322:05PRNUSCumberland Pharmaceuticals Reports Revenue and Earnings..
01/8/202322:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023..
30/6/202323:20EDGAR2Form 8-K - Current report
26/6/202315:00PRNUSNEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN..
23/5/202315:00PRNUSCUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND..
15/5/202315:00PRNUSCALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN..
09/5/202322:05PRNUSCumberland Pharmaceuticals Reports First Quarter 2023..
02/5/202322:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2023..

Dernières Valeurs Consultées

NASDAQ
CPIX
Cumberland Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés